ProCE Banner Activity

Use of a Pharmacogenomics-Driven Machine Learning Approach to Predict Patient Response to Methotrexate

Slideset Download
Conference Coverage
In early RA, pharmacogenomics biomarkers may be useful in guiding effective RA treatment choices and need for treatment escalation.

Released: November 11, 2020

Expiration: November 10, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Gilead Sciences, Inc.

Sanofi Genzyme Corp